Francesco Barretta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francesco Barretta has a total of 620 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Gronchi
Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
19 shared publications - Marco Fiore
Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
19 shared publications - Maura Massimino
Pediatric Oncology Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
18 shared publications - Giovanni Grignani
Candiolo Cancer Institute FPO-IRCCS Strada Provinciale 142 Km 3.95 10060 Candiolo TO Italy
17 shared publications - Jean-Yves Blay
Medical Oncology Department Centre Léon Bérard Lyon France
16 shared publications - Paola Collini
Soft Tissue Tumor Pathology Unit, Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
16 shared publications
Latest Publications
- Open Access
Psychosocial, Neuropsychological, Academic, and Social Outcomes in Pediatric Solid Tumor Survivors: An Exploratory Parent-Reported Study
Background/Objectives: Psychosocial, neuropsychological, social, and academic difficulties may persist after pediatric cancer treatment. We described parent/caregiver-reported functioning and support needs and explored their associations with clinical, family-related, socio-economic, premorbid, and place-based characteristics in an Italian survivorship setting. Methods: This single-center cross-sectional exploratory study included 93 of 130 families approached between November 2022 and January 2023 (response rate, 71.5%). One parent or caregiver completed a purpose-built questionnaire for each survivor. The cohort included 38 survivors with central nervous system (CNS) tumors and 55 with non-CNS tumors. Outcomes were evaluated relative to retrospectively reported pre-diagnosis functioning. Exact confidence intervals, effect estimates, multivariable Firth logistic regression, and Benjamini–Hochberg false discovery rate correction were used. Results: Worsening internalizing difficulties were reported for 48/90 survivors (53.3%), neuropsychological difficulties for 42/90 (46.7%), academic worsening for 30/85 (35.3%), and social integration difficulties for 27/90 (30.0%). CNS survivors more frequently had social integration difficulties than non-CNS survivors (47.4% versus 17.3%; odds ratio, 4.22; 95% confidence interval, 1.50–12.73; q = 0.015) and underwent cognitive assessment after cancer (50.0% versus 17.0%; odds ratio, 4.80; 95% confidence interval, 1.71–14.44; q = 0.013). Municipality size and geographic area showed no nominal associations with parent-reported outcomes. No candidate-variable association in the exploratory screen remained significant after false discovery rate correction. Conclusions: Parent-reported difficulties and support needs were common, with differences by CNS versus non-CNS tumor site. Family-related, premorbid, and place-based patterns are hypothesis-generating and require prospective evaluation using validated multi-informant measures.
Open AccessPsychosocial, Neuropsychological, Academic, and Social Outcomes in Pediatric Solid Tumor Survivors: An Exploratory Parent-Reported Study
Background/Objectives: Psychosocial, neuropsychological, social, and academic difficulties may persist after pediatric cancer treatment. We described parent/caregiver-reported functioning and support needs and explored their associations with clinical, family-related, socio-economic, premorbid, and place-based characteristics in an Italian survivorship setting. Methods: This single-center cross-sectional exploratory study included 93 of 130 families approached between November 2022 and January 2023 (response rate, 71.5%). One parent or caregiver completed a purpose-built questionnaire for each survivor. The cohort included 38 survivors with central nervous system (CNS) tumors and 55 with non-CNS tumors. Outcomes were evaluated relative to retrospectively reported pre-diagnosis functioning. Exact confidence intervals, effect estimates, multivariable Firth logistic regression, and Benjamini–Hochberg false discovery rate correction were used. Results: Worsening internalizing difficulties were reported for 48/90 survivors (53.3%), neuropsychological difficulties for 42/90 (46.7%), academic worsening for 30/85 (35.3%), and social integration difficulties for 27/90 (30.0%). CNS survivors more frequently had social integration difficulties than non-CNS survivors (47.4% versus 17.3%; odds ratio, 4.22; 95% confidence interval, 1.50–12.73; q = 0.015) and underwent cognitive assessment after cancer (50.0% versus 17.0%; odds ratio, 4.80; 95% confidence interval, 1.71–14.44; q = 0.013). Municipality size and geographic area showed no nominal associations with parent-reported outcomes. No candidate-variable association in the exploratory screen remained significant after false discovery rate correction. Conclusions: Parent-reported difficulties and support needs were common, with differences by CNS versus non-CNS tumor site. Family-related, premorbid, and place-based patterns are hypothesis-generating and require prospective evaluation using validated multi-informant measures.
- Open Access
- 15 June 2026
- Published by MDPI AG in Preprints.org
Psychosocial, Neuropsychological, Academic, and Social Outcomes in Pediatric Solid Tumor Survivors: An Exploratory Parent-Reported Study
Background/Objectives: Long-term psychosocial/neurocognitive sequelae are frequently observed in survivors of pedi-atric cancer and adversely affect quality of life in adulthood. Although clinical predictors are well established, the con-tribution of familial, cultural, and socio-economic factors has received less attention. Methods: Between November 2022-January 2023, 93 survivors parents of pediatric patients with solid tumors including 38 individuals with central nervous system (CNS) tumors, completed a specifically designed 60-item questionnaire. Outcomes were evaluated across four domains—psychological, neurocognitive, academic, and social—along with a broad range of potential pre-dictors encompassing demographic, clinical, family-related, cultural, socio-economic, and premorbid characteristics. Statistical analyses included Fisher’s exact test and non-parametric methods. Results: New-onset or aggravated inter-nalizing symptoms were reported in 53% of survivors, externalizing behaviors in 32%, neurocognitive impairments in 45%. Academic difficulties were identified in 32%, with 25% requiring an Individualized-Education-Plan. Social chal-lenges affected 30% of participants and were more prevalent among CNS tumor survivors, who also demonstrated greater functional losses and rehabilitation needs. Lower parental educational attainment was associated with exter-nalizing symptoms (p = 0.039), whereas household income, parental occupation, and residential setting were not. Premorbid psychological or learning difficulties were strong predictors of adverse outcomes (all p < 0.01). Older paternal age was protective for relational and academic functioning, while having more siblings was linked to increased cogni-tive risk. Conclusions: Psychosocial and neurocognitive late effects remain common among pediatric cancer survivors. Educational background and premorbid vulnerabilities appear more influential than economic factors, supporting the need for targeted neuropsychological surveillance and family-centered screening strategies.
- 15 June 2026
- Published by MDPI AG in Preprints.org
Open AccessPsychosocial, Neuropsychological, Academic, and Social Outcomes in Pediatric Solid Tumor Survivors: An Exploratory Parent-Reported Study
Background/Objectives: Long-term psychosocial/neurocognitive sequelae are frequently observed in survivors of pedi-atric cancer and adversely affect quality of life in adulthood. Although clinical predictors are well established, the con-tribution of familial, cultural, and socio-economic factors has received less attention. Methods: Between November 2022-January 2023, 93 survivors parents of pediatric patients with solid tumors including 38 individuals with central nervous system (CNS) tumors, completed a specifically designed 60-item questionnaire. Outcomes were evaluated across four domains—psychological, neurocognitive, academic, and social—along with a broad range of potential pre-dictors encompassing demographic, clinical, family-related, cultural, socio-economic, and premorbid characteristics. Statistical analyses included Fisher’s exact test and non-parametric methods. Results: New-onset or aggravated inter-nalizing symptoms were reported in 53% of survivors, externalizing behaviors in 32%, neurocognitive impairments in 45%. Academic difficulties were identified in 32%, with 25% requiring an Individualized-Education-Plan. Social chal-lenges affected 30% of participants and were more prevalent among CNS tumor survivors, who also demonstrated greater functional losses and rehabilitation needs. Lower parental educational attainment was associated with exter-nalizing symptoms (p = 0.039), whereas household income, parental occupation, and residential setting were not. Premorbid psychological or learning difficulties were strong predictors of adverse outcomes (all p < 0.01). Older paternal age was protective for relational and academic functioning, while having more siblings was linked to increased cogni-tive risk. Conclusions: Psychosocial and neurocognitive late effects remain common among pediatric cancer survivors. Educational background and premorbid vulnerabilities appear more influential than economic factors, supporting the need for targeted neuropsychological surveillance and family-centered screening strategies.
- 24 April 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 177 (3) , 124
Surgery and radiotherapy strategies at first relapse of pediatric intracranial ependymoma: an Italian retrospective study integrating molecular subgrouping
- 24 April 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 177 (3) , 124
Surgery and radiotherapy strategies at first relapse of pediatric intracranial ependymoma: an Italian retrospective study integrating molecular subgrouping
- Open Access
Mucosal Melanoma of the Head and Neck: A 45-Year Experience of a Tertiary Cancer Center
Background/Objectives. Head and neck mucosal melanoma (HNMM) is a rare, aggressive malignancy with poor outcomes and limited evidence to guide prognostication and treatment. A detailed assessment of long-term survival and prognostic factors is needed to inform clinical management and staging. This work aimed to describe outcomes and prognostic factors in HNMM patients treated over 45 years. Methods. This was a retrospective observational cohort study of consecutive patients treated at a tertiary referral center in Italy from 1975 to 2020. Random-forest-based screening informed covariate selection for Cox models. Endpoints were overall survival (OS), disease-free survival (DFS), and post-recurrence DFS (prDFS). Associations with clinical and pathological variables were evaluated using Kaplan–Meier estimates, log-rank tests, and multivariable Cox regression. Results. Among 112 patients (median follow-up, 121.1 months), 3-/5-year OS was 42.8%/28.0%, DFS 20.5%/13.2%, and 1-/3-year prDFS 36.7%/10.9%. Ulceration was associated with worse OS (HR 2.12; 95% CI 1.05–4.26) and DFS (HR 2.23; 95% CI 1.16–4.28). Male sex showed a trend toward poorer OS and DFS. Regional lymph-node treatment correlated strongly with OS and prDFS (overall p < 0.001), with neck dissection indicating unfavorable risk (OS HR 5.22; 95% CI 2.39–11.40). Conclusions. HNMM remains a high-mortality disease with frequent recurrence. Ulceration and nodal involvement were key adverse prognostic factors, while surgery was associated with improved survival. The findings support incorporating ulceration into future staging and highlight the potential for durable control through salvage surgery. Further investigation of treatment intensification, biomarkers, and multimodal strategies is warranted.
Open AccessMucosal Melanoma of the Head and Neck: A 45-Year Experience of a Tertiary Cancer Center
Background/Objectives. Head and neck mucosal melanoma (HNMM) is a rare, aggressive malignancy with poor outcomes and limited evidence to guide prognostication and treatment. A detailed assessment of long-term survival and prognostic factors is needed to inform clinical management and staging. This work aimed to describe outcomes and prognostic factors in HNMM patients treated over 45 years. Methods. This was a retrospective observational cohort study of consecutive patients treated at a tertiary referral center in Italy from 1975 to 2020. Random-forest-based screening informed covariate selection for Cox models. Endpoints were overall survival (OS), disease-free survival (DFS), and post-recurrence DFS (prDFS). Associations with clinical and pathological variables were evaluated using Kaplan–Meier estimates, log-rank tests, and multivariable Cox regression. Results. Among 112 patients (median follow-up, 121.1 months), 3-/5-year OS was 42.8%/28.0%, DFS 20.5%/13.2%, and 1-/3-year prDFS 36.7%/10.9%. Ulceration was associated with worse OS (HR 2.12; 95% CI 1.05–4.26) and DFS (HR 2.23; 95% CI 1.16–4.28). Male sex showed a trend toward poorer OS and DFS. Regional lymph-node treatment correlated strongly with OS and prDFS (overall p < 0.001), with neck dissection indicating unfavorable risk (OS HR 5.22; 95% CI 2.39–11.40). Conclusions. HNMM remains a high-mortality disease with frequent recurrence. Ulceration and nodal involvement were key adverse prognostic factors, while surgery was associated with improved survival. The findings support incorporating ulceration into future staging and highlight the potential for durable control through salvage surgery. Further investigation of treatment intensification, biomarkers, and multimodal strategies is warranted.
- Open Access
- 3 February 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 92
Early recurrence and prognosis in patients undergoing resection of primary retroperitoneal sarcoma: an international, retrospective cohort study
- 3 February 2026
- Published by Elsevier in eClinicalMedicine
- Vol. 92
Open AccessEarly recurrence and prognosis in patients undergoing resection of primary retroperitoneal sarcoma: an international, retrospective cohort study
- 20 January 2026
- Published by SAGE Publications in Tumori Journal
- Vol. 112 (1) , 32-39
Volunteering in a pediatric oncology unit: Motivations and duration
Background: Volunteers play an essential role in pediatric oncology. While they are driven by personal motivations, they usually receive specific training that may support or reshape their goals. Methods: We conducted a questionnaire-based survey to assess demographics, motivations, and satisfaction among eight associations/non-profit organizations, representing approximately 120 volunteers. The objectives were to explore the nature and correlations of their motivations to evaluate the sustainability of their engagement. Results: Sixty-nine volunteers completed the questionnaire, either in full or in part. Most respondents were women, with a median age of 59 years, a medium-to-high educational level, and more than five years of experience in volunteering. Their commitment was mainly driven by personal/family experiences with childhood cancer. They demonstrated a strong awareness of cancer-related issues and were motivated by the desire to improve the quality and innovation of care. Participation within associations fostered a sense of community and altruistic purposes. High levels of satisfaction often led them to encourage others to volunteer. Previous rewards or recognition were not considered a major motivating factor. Conclusions: Effective volunteer engagement and retention depend on a clear understanding of volunteers’ expectations and on the selective recruitment of individuals whose goals align with the organization’s capacity to meet them.
- 20 January 2026
- Published by SAGE Publications in Tumori Journal
- Vol. 112 (1) , 32-39
Volunteering in a pediatric oncology unit: Motivations and duration
Background: Volunteers play an essential role in pediatric oncology. While they are driven by personal motivations, they usually receive specific training that may support or reshape their goals. Methods: We conducted a questionnaire-based survey to assess demographics, motivations, and satisfaction among eight associations/non-profit organizations, representing approximately 120 volunteers. The objectives were to explore the nature and correlations of their motivations to evaluate the sustainability of their engagement. Results: Sixty-nine volunteers completed the questionnaire, either in full or in part. Most respondents were women, with a median age of 59 years, a medium-to-high educational level, and more than five years of experience in volunteering. Their commitment was mainly driven by personal/family experiences with childhood cancer. They demonstrated a strong awareness of cancer-related issues and were motivated by the desire to improve the quality and innovation of care. Participation within associations fostered a sense of community and altruistic purposes. High levels of satisfaction often led them to encourage others to volunteer. Previous rewards or recognition were not considered a major motivating factor. Conclusions: Effective volunteer engagement and retention depend on a clear understanding of volunteers’ expectations and on the selective recruitment of individuals whose goals align with the organization’s capacity to meet them.
- 22 October 2025
- Published by SAGE Publications in Tumori Journal
- Vol. 111 (6) , 472-477
Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events
Introduction: The highest percentage of our patients referred to Pediatric Palliative Care (PPC) are those with brain tumors. Of these, we analyzed PPC activation modes and timing, occurrence of acute events during the period of PPC activation, and the time between acute event and death. Methods: During the period 1 January 2010 to 31 October 2023 approximately 1000 Cranial Nervous System (CNS) tumor patients were treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. All records of patients with CNS tumors who were treated and who died during this period were retrieved and retrospectively analyzed. Results: Data on 107 patients were retrieved. At the time of being taken over by PPC service, 32 patients were at diagnosis stage and 75 were beyond first-line of treatment. At diagnosis, 31 patients had already undergone surgery for placement of a ventriculoperitoneal shunt due to acute intracranial hypertension (IH). Twenty-nine out of 107 patients suffered an emergency while already managed by PPC service. In 18 out of 29 cases, emergency was an acute IH episode. Median time from diagnosis to PPC activation and from diagnosis to death (Overall Survival) were 12.1 months (6.2-27.3) and 16.7 months (10.8-31.1), respectively. Sixty-two patients died at home, 32 were admitted to and died in the referring hospice, 13 died in different hospitals. Conclusions: Management of a “complex” pediatric patient with an unfavorable prognosis requires early activation of PPC, with a seamless continuation of the already existing partnerships between family, pediatric-oncology team, referring neurosurgeon and palliative care teams.
- 22 October 2025
- Published by SAGE Publications in Tumori Journal
- Vol. 111 (6) , 472-477
Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events
Introduction: The highest percentage of our patients referred to Pediatric Palliative Care (PPC) are those with brain tumors. Of these, we analyzed PPC activation modes and timing, occurrence of acute events during the period of PPC activation, and the time between acute event and death. Methods: During the period 1 January 2010 to 31 October 2023 approximately 1000 Cranial Nervous System (CNS) tumor patients were treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. All records of patients with CNS tumors who were treated and who died during this period were retrieved and retrospectively analyzed. Results: Data on 107 patients were retrieved. At the time of being taken over by PPC service, 32 patients were at diagnosis stage and 75 were beyond first-line of treatment. At diagnosis, 31 patients had already undergone surgery for placement of a ventriculoperitoneal shunt due to acute intracranial hypertension (IH). Twenty-nine out of 107 patients suffered an emergency while already managed by PPC service. In 18 out of 29 cases, emergency was an acute IH episode. Median time from diagnosis to PPC activation and from diagnosis to death (Overall Survival) were 12.1 months (6.2-27.3) and 16.7 months (10.8-31.1), respectively. Sixty-two patients died at home, 32 were admitted to and died in the referring hospice, 13 died in different hospitals. Conclusions: Management of a “complex” pediatric patient with an unfavorable prognosis requires early activation of PPC, with a seamless continuation of the already existing partnerships between family, pediatric-oncology team, referring neurosurgeon and palliative care teams.
- Open Access
- 13 October 2025
- Published by Wiley
Beyond Demographic and Clinical Factors: The Influence of Family, Cultural and Socio-Economic Factors on Psychological, Neuropsychological, Social and Academic Outcome in Children Treated for Oncological Disease
Background . Late psychosocial and neurocognitive effects are common in pediatric cancer survivors and may compromise long-term quality of life. While clinical risk factors are well studied, the influence of family, cultural, and socio-economic variables remains less explored. Methods . Between November 2022 and January 2023, 93 survivors of pediatric solid tumors (median age 16.2 years; median 52.5 months from diagnosis) completed a purpose-built 60-item parental questionnaire. Four outcome domains were assessed (psychological, neuropsychological, academic, social), alongside determinants across demographic, clinical, family, cultural, socio-economic, and premorbid areas. Associations were examined using Fisher’s exact test and non-parametric statistics. Results . Internalizing symptoms emerged or worsened in 52% of survivors, externalizing behaviors in 31%, and neuropsychological difficulties in 45%. Academic decline affected 32%, with 25% requiring an Individualized Education Plan. Social problems occurred in 29%, disproportionately among central nervous system (CNS) tumor survivors, who also showed greater loss of adaptive resources and rehabilitation needs. Lower parental education was significantly associated with externalizing problems (p = 0.039), while income, occupation, and residence were not. Premorbid psychological or scholastic issues strongly predicted post-treatment sequelae (all p < 0.01). Older paternal age reduced relational and scholastic difficulties, whereas larger sibling groups increased cognitive vulnerability. Conclusions . Psychosocial and neurocognitive late effects remain frequent in pediatric cancer survivorship, particularly after CNS tumors. Family educational level and premorbid vulnerabilities, rather than economic status, significantly influence outcomes. Tailored neuropsychological follow-up for CNS survivors and family-focused screening for others may optimize rehabilitation and long-term care.
- 13 October 2025
- Published by Wiley
Open AccessBeyond Demographic and Clinical Factors: The Influence of Family, Cultural and Socio-Economic Factors on Psychological, Neuropsychological, Social and Academic Outcome in Children Treated for Oncological Disease
Background . Late psychosocial and neurocognitive effects are common in pediatric cancer survivors and may compromise long-term quality of life. While clinical risk factors are well studied, the influence of family, cultural, and socio-economic variables remains less explored. Methods . Between November 2022 and January 2023, 93 survivors of pediatric solid tumors (median age 16.2 years; median 52.5 months from diagnosis) completed a purpose-built 60-item parental questionnaire. Four outcome domains were assessed (psychological, neuropsychological, academic, social), alongside determinants across demographic, clinical, family, cultural, socio-economic, and premorbid areas. Associations were examined using Fisher’s exact test and non-parametric statistics. Results . Internalizing symptoms emerged or worsened in 52% of survivors, externalizing behaviors in 31%, and neuropsychological difficulties in 45%. Academic decline affected 32%, with 25% requiring an Individualized Education Plan. Social problems occurred in 29%, disproportionately among central nervous system (CNS) tumor survivors, who also showed greater loss of adaptive resources and rehabilitation needs. Lower parental education was significantly associated with externalizing problems (p = 0.039), while income, occupation, and residence were not. Premorbid psychological or scholastic issues strongly predicted post-treatment sequelae (all p < 0.01). Older paternal age reduced relational and scholastic difficulties, whereas larger sibling groups increased cognitive vulnerability. Conclusions . Psychosocial and neurocognitive late effects remain frequent in pediatric cancer survivorship, particularly after CNS tumors. Family educational level and premorbid vulnerabilities, rather than economic status, significantly influence outcomes. Tailored neuropsychological follow-up for CNS survivors and family-focused screening for others may optimize rehabilitation and long-term care.
- Open Access
- 19 August 2025
- Published by Wiley
Volunteering in a Pediatric oncology unit: motivations and duration
Background . The presence of volunteers is a great and essential help in pediatric oncology life. Volunteers generally receive an appropriate formation that could follow their motivations or modify finalities. Methods . We investigated, through an appropriate questionnaire, demography, motivations and satisfaction of eight association/non-profit entities. Results. Sixty-nine volunteers answered anonymously to all or part of the questions. The majority of them, with a median age of 59 years, were females, with a medium/high-level of education and were involved longer than 5 years in volunteering. Their engagement was driven by personal or close experiences with childhood cancer. They possessed a deep understanding of cancer-related issues and were motivated by the desire to enhance the quality and innovation of care. Participation through associations fostered a sense of community belonging and altruistic purpose, and their satisfaction with the experience often led them to encourage others to become involved. The majority of respondents did not consider rewards from previous experiences to be a significant motivating factor. Conclusions . Effective volunteer activities and retention rely on a clear understanding of volunteers’ expectations and the selective recruitment of individuals whose expectations align with what the organization can feasibly provide.
- 19 August 2025
- Published by Wiley
Open AccessVolunteering in a Pediatric oncology unit: motivations and duration
Background . The presence of volunteers is a great and essential help in pediatric oncology life. Volunteers generally receive an appropriate formation that could follow their motivations or modify finalities. Methods . We investigated, through an appropriate questionnaire, demography, motivations and satisfaction of eight association/non-profit entities. Results. Sixty-nine volunteers answered anonymously to all or part of the questions. The majority of them, with a median age of 59 years, were females, with a medium/high-level of education and were involved longer than 5 years in volunteering. Their engagement was driven by personal or close experiences with childhood cancer. They possessed a deep understanding of cancer-related issues and were motivated by the desire to enhance the quality and innovation of care. Participation through associations fostered a sense of community belonging and altruistic purpose, and their satisfaction with the experience often led them to encourage others to become involved. The majority of respondents did not consider rewards from previous experiences to be a significant motivating factor. Conclusions . Effective volunteer activities and retention rely on a clear understanding of volunteers’ expectations and the selective recruitment of individuals whose expectations align with what the organization can feasibly provide.
- Open Access
- 30 May 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (8) , e31808
Pediatric Craniofacial Osteosarcoma: The Milano Experience
Background: Craniofacial osteosarcoma (CFOS) is a rare tumor, typically affecting patients over 60, with a low incidence of metastasis at diagnosis as well as at relapse.Patients and methods: This study analyzed patients treated for high‐grade CFOS at Fondazione IRCCS Istituto Nazionale dei Tumori between 1991 and 2021, focusing on histological characteristics, systemic and local treatment, and outcome.Results: Eleven patients (7F/4M) were included, with a median age of 15 years. Eight patients had an unfavorable site of origin (maxilla, cranial fossae, skull), seven had an unfavorable histology (i.e., chondroblastic subtype), and four had a high‐grade tumor (G4). Five had both unfavorable histology and primary tumor site, and three of the five a G4 tumor. Chemotherapy (MAP or MAPI regimen) was administered to all, with five receiving neoadjuvant treatment. Surgery was performed on all, achieving clear margins in eight patients (four of them had received neoadjuvant CT). Two of three patients with R1 surgery received adjuvant radiotherapy (RT) and are still alive and disease‐free. Three patients died of relapse, all with unfavorable primary tumor sites, G4 tumors, and two with unfavorable histology; one patient with positive margins had not received RT. At a median follow‐up of 65.8 months, 5‐year PFS was 100% for favorable tumor sites, 50% for unfavorable sites, and 85% for G3 tumors compared to 25% for G4 tumors.Conclusion: Unfavorable tumor sites and G4 tumors may be indicative of a worse prognosis, especially as all relapsed patients had both. RT should be considered for R1 surgery. Due to the disease's rarity and complexity, specialized centers with expertise in head and neck sarcoma are essential for managing these patients.
- 30 May 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (8) , e31808
Open AccessPediatric Craniofacial Osteosarcoma: The Milano Experience
Background: Craniofacial osteosarcoma (CFOS) is a rare tumor, typically affecting patients over 60, with a low incidence of metastasis at diagnosis as well as at relapse.Patients and methods: This study analyzed patients treated for high‐grade CFOS at Fondazione IRCCS Istituto Nazionale dei Tumori between 1991 and 2021, focusing on histological characteristics, systemic and local treatment, and outcome.Results: Eleven patients (7F/4M) were included, with a median age of 15 years. Eight patients had an unfavorable site of origin (maxilla, cranial fossae, skull), seven had an unfavorable histology (i.e., chondroblastic subtype), and four had a high‐grade tumor (G4). Five had both unfavorable histology and primary tumor site, and three of the five a G4 tumor. Chemotherapy (MAP or MAPI regimen) was administered to all, with five receiving neoadjuvant treatment. Surgery was performed on all, achieving clear margins in eight patients (four of them had received neoadjuvant CT). Two of three patients with R1 surgery received adjuvant radiotherapy (RT) and are still alive and disease‐free. Three patients died of relapse, all with unfavorable primary tumor sites, G4 tumors, and two with unfavorable histology; one patient with positive margins had not received RT. At a median follow‐up of 65.8 months, 5‐year PFS was 100% for favorable tumor sites, 50% for unfavorable sites, and 85% for G3 tumors compared to 25% for G4 tumors.Conclusion: Unfavorable tumor sites and G4 tumors may be indicative of a worse prognosis, especially as all relapsed patients had both. RT should be considered for R1 surgery. Due to the disease's rarity and complexity, specialized centers with expertise in head and neck sarcoma are essential for managing these patients.